What is Aro Biotherapeutics worth?
$181.5Mlast known valuation
Aro Biotherapeutics last raised $24.0M in its Early Stage VC (Dec 2022).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Aro Biotherapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2022 | Early Stage VC | $24.0M | ▮ | ▮ |
| Dec 2020 | Later Stage VC | $90.3M | ▮ | ▮ |
| Dec 2019 | Early Stage VC | $5.0M | ▮ | ▮ |
| Mar 2019 | Seed Round | $3.5M | ▮ | ▮ |
How Aro Biotherapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Aro Biotherapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Aro Biotherapeutics worth?
- Aro Biotherapeutics's last known valuation is $181.5M.
- How much has Aro Biotherapeutics raised?
- Aro Biotherapeutics has raised $131.8M in total funding across 4 recorded rounds.
- When did Aro Biotherapeutics last raise?
- Aro Biotherapeutics last raised in Dec 2022 (Early Stage VC), raising $24.0M.